Physician profile
Candace Vielma
NPI 1992266241
$1,272.44
in general payments reported to CMS, 2019-2025
10 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Gerontology (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.32 · 2022: $13.83 · 2023: $589 · 2024: $190 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $335.11 | 2023-2024 | Cardiomems |
| Impulse Dynamics (USA) INC. | $313.65 | 2023 | Optimizer |
| Boston Scientific Corporation | $130.12 | 2023-2024 | Resonate El Icd Vr, Watchman Flx |
| Scpharmaceuticals INC. | $116.15 | 2025 | |
| Amgen INC. | $110.41 | 2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $110.26 | 2025 | Camzyos |
| Novo Nordisk INC | $105.94 | 2025 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $19.65 | 2025 | |
| Abbvie INC. | $17.32 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Vielma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.